Mangoceuticals converts $500k debt to equity at $1.50/share; licenses Dermytol skin care for 650k shares

MANGOCEUTICALS, INC.

Entered First Amendment with MAAB Global to convert $500,000 debt into up to 333,334 shares at $1.50/share.
Signed Master Distribution Agreement with Propre Energie for Dermytol® formulations; pays 650,000 restricted shares and 1% gross sales revenue.
Assigned rights under two Epiq Scripts agreements to subsidiary M&P; CEO Jacob Cohen is 51% owner of Epiq Scripts.
Entered LT Global Practice Management Service Agreement (CEO's wife's company) for virtual professionals at $1,800-$3,500 each.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.